Cargando…

Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease

BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including eviden...

Descripción completa

Detalles Bibliográficos
Autores principales: Horri, Negar, Farmani, Mahboube, Ghassami, Mahmoud, Haghighi, Sassan, Amini, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252768/
https://www.ncbi.nlm.nih.gov/pubmed/22247728
_version_ 1782220667907735552
author Horri, Negar
Farmani, Mahboube
Ghassami, Mahmoud
Haghighi, Sassan
Amini, Massoud
author_facet Horri, Negar
Farmani, Mahboube
Ghassami, Mahmoud
Haghighi, Sassan
Amini, Massoud
author_sort Horri, Negar
collection PubMed
description BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including evidences for nephropathy and ischemic heart disease, demographic characteristics, blood pressure and body mass index were collected, and then patients were divided into 3 groups based on their best corrected visual acuity in the better-seeing eye. Analysis of variance was used to compare basic characteristics according to different levels of visual acuity. RESULTS: The prevalence of blindness and low vision was 5.5% and 13.3% respectively, and as age, duration of diabetes, systolic blood pressure and body mass index increased, the visual acuity decreased. The prevalence of hypertension and obesity in patients with visual disabilities was significantly higher than in patients with not impaired visions (p = 0.008 and p = 0.02, respectively). We also found that with greater decline in visual acuity, the prevalence of neph-ropathy and ischemic heart diseases increased. CONCLUSIONS: The factors related to retinopathy play a role in affecting the degree of visual impairment in diabetic patients. Therefore, controlling risk factors can be useful in decreasing impairment of vision and blindness.
format Online
Article
Text
id pubmed-3252768
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32527682012-01-13 Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease Horri, Negar Farmani, Mahboube Ghassami, Mahmoud Haghighi, Sassan Amini, Massoud J Res Med Sci Original Article BACKGROUND: The aim of this study was to investigate the risk factors of low vision in type 2 diabetic patients and the prevalence of ischemic heart diseases and nephropathy for different visual acuities. METHODS: In this cross-sectional study, data from 738 type 2 diabetic patients including evidences for nephropathy and ischemic heart disease, demographic characteristics, blood pressure and body mass index were collected, and then patients were divided into 3 groups based on their best corrected visual acuity in the better-seeing eye. Analysis of variance was used to compare basic characteristics according to different levels of visual acuity. RESULTS: The prevalence of blindness and low vision was 5.5% and 13.3% respectively, and as age, duration of diabetes, systolic blood pressure and body mass index increased, the visual acuity decreased. The prevalence of hypertension and obesity in patients with visual disabilities was significantly higher than in patients with not impaired visions (p = 0.008 and p = 0.02, respectively). We also found that with greater decline in visual acuity, the prevalence of neph-ropathy and ischemic heart diseases increased. CONCLUSIONS: The factors related to retinopathy play a role in affecting the degree of visual impairment in diabetic patients. Therefore, controlling risk factors can be useful in decreasing impairment of vision and blindness. Medknow Publications & Media Pvt Ltd 2011-03 /pmc/articles/PMC3252768/ /pubmed/22247728 Text en Copyright: © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Horri, Negar
Farmani, Mahboube
Ghassami, Mahmoud
Haghighi, Sassan
Amini, Massoud
Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title_full Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title_fullStr Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title_full_unstemmed Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title_short Visual acuity in an Iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
title_sort visual acuity in an iranian cohort of patients with type 2 diabetes: the role of nephropathy and ischemic heart disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252768/
https://www.ncbi.nlm.nih.gov/pubmed/22247728
work_keys_str_mv AT horrinegar visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease
AT farmanimahboube visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease
AT ghassamimahmoud visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease
AT haghighisassan visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease
AT aminimassoud visualacuityinaniraniancohortofpatientswithtype2diabetestheroleofnephropathyandischemicheartdisease